Cryofocus Medtech (Shanghai) Co., Ltd.

SEHK:6922 Stock Report

Market Cap: HK$1.7b

Cryofocus Medtech (Shanghai) Valuation

Is 6922 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

0/6

Valuation Score 0/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • Price-To-Sales vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of 6922 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: Insufficient data to calculate 6922's fair value for valuation analysis.

Significantly Below Fair Value: Insufficient data to calculate 6922's fair value for valuation analysis.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for 6922?

Key metric: As 6922 is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for 6922. This is calculated by dividing 6922's market cap by their current revenue.
What is 6922's PS Ratio?
PS Ratio37.5x
SalesCN¥41.51m
Market CapCN¥1.56b

Price to Sales Ratio vs Peers

How does 6922's PS Ratio compare to its peers?

The above table shows the PS ratio for 6922 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PSEstimated GrowthMarket Cap
Peer Average3.1x
2160 MicroPort CardioFlow Medtech
3.9x23.5%HK$1.6b
1358 PW Medtech Group
2.1xn/aHK$1.6b
1696 Sisram Medical
0.5x12.8%HK$1.5b
2235 MicroTech Medical (Hangzhou)
6x41.0%HK$1.9b
6922 Cryofocus Medtech (Shanghai)
37.5xn/aHK$1.7b

Price-To-Sales vs Peers: 6922 is expensive based on its Price-To-Sales Ratio (37.5x) compared to the peer average (3.1x).


Price to Sales Ratio vs Industry

How does 6922's PS Ratio compare vs other companies in the HK Medical Equipment Industry?

5 CompaniesPrice / SalesEstimated GrowthMarket Cap
1763 China Isotope & Radiation
0.5xn/aUS$442.36m
1120 Arts Optical International Holdings
0.3xn/aUS$41.20m
1612 Vincent Medical Holdings
0.4x18.0%US$33.59m
2393 Yestar Healthcare Holdings
0.06xn/aUS$20.68m
6922 37.5xIndustry Avg. 3.2xNo. of Companies5PS0246810+
5 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Sales vs Industry: 6922 is expensive based on its Price-To-Sales Ratio (37.5x) compared to the Hong Kong Medical Equipment industry average (3.2x).


Price to Sales Ratio vs Fair Ratio

What is 6922's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

6922 PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio37.5x
Fair PS Ration/a

Price-To-Sales vs Fair Ratio: Insufficient data to calculate 6922's Price-To-Sales Fair Ratio for valuation analysis.


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.


Discover undervalued companies